← Leaderboards
Katherine Ann Fantauzzo
Icahn School Of Medicine At Mount Sinai
$4,512,197
Attributed
$4,512,197
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.1M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,512,197 · 5
By mechanism
R01$3,523,560 · 2
K02$626,655 · 1
R03$254,250 · 1
F32$107,732 · 1
Top collaborators
No co-investigators on record.
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Bruce D Gelb$39,999,464
- Jeffrey Ohmann Bush$16,044,315
- Cathie M Pfleger$5,183,455
- Harm Van Bakel$10,134,091
- Emeline Laure Maillet$164,584
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexInsightCell PhysiologyPlatelet-Derived Growth FactorSignal TransductionEmbryoPlayMutant Mouse ModelNovel TherapeuticsPhenotypeProteinsCraniofacialIn VivoLigandsMesenchymeCongenital AbnormalityMutantCellsAllelesReceptor Protein-Tyrosine KinasesCraniofacial DevelopmentAblationNeural Crest CellLive Birth
Grant awards (20)
Srsf3-mediated alternative RNA splicing in craniofacial development$499,870
R01 · FY2025 · DE · contact PI
Srsf3-mediated alternative RNA splicing in craniofacial development$486,137
R01 · FY2023 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$125,331
K02 · FY2023 · DE · contact PI
Srsf3-mediated alternative RNA splicing in craniofacial development$493,847
R01 · FY2022 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$360,558
R01 · FY2022 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$125,331
K02 · FY2022 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$113,174
R01 · FY2022 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$364,200
R01 · FY2021 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$125,331
K02 · FY2021 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$113,174
R01 · FY2021 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$364,200
R01 · FY2020 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$125,331
K02 · FY2020 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$364,200
R01 · FY2019 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$125,331
K02 · FY2019 · DE · contact PI
Characterization of PDGFR dimer-specific dynamics in the craniofacial mesenchyme$364,200
R01 · FY2018 · DE · contact PI
PDGFRbeta signaling in craniofacial development$89,094
R03 · FY2016 · DE · contact PI
PDGFRbeta signaling in craniofacial development.$38,031
R03 · FY2016 · DE · contact PI
PDGFRbeta signaling in craniofacial development.$127,125
R03 · FY2015 · DE · contact PI
PI3K/Akt-mediated PDGFRalpha signaling in craniofacial development$54,742
F32 · FY2013 · DE · contact PI
PI3K/Akt-mediated PDGFRalpha signaling in craniofacial development$52,990
F32 · FY2012 · DE · contact PI